The global cystic fibrosis market is on track for substantial expansion in the coming years, fueled by advancements in treatment options and a growing patient population. According to a recent industry report, the market, valued at US 6.02 billion in 2023, is expected to reach US$ 16.46 billion by 2031, reflecting a robust compound annual growth rate (CAGR) of 13.4% over the forecast...